Expression of podoplanin correlates with prognosis in nasopharyngeal carcinoma.

Philipp WolberDavid SchwarzMaximilian NiemczykUta DrebberJens Peter KlußmannMoritz Meyer

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2020)

This retrospective study shows that podoplanin expression is a potential prognostic marker for nasopharyngeal carcinomas. In the future, clinical use could filter out more aggressive courses and allow therapy escalation in those cases.

Keyphrases

poor prognosis
binding protein
high grade
randomized controlled trial
current status
risk assessment
bone marrow
mesenchymal stem cells